Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

256
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

746
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
746
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.4K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

367
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
367
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystatin-C Versus Creatinine and Kidney Function in Heart Failure With Preserved Ejection Fraction: A SOGALDI-PEF Analysis.

The American journal of cardiology·2026
Same author

Factors associated with nurses' physical and psychological quality of life during the COVID-19 pandemic: a multicentre analytical cross-sectional study.

BMC nursing·2026
Same author

Screening for HFpEF in pacemaker patients: Study design and protocol of the PM-HFpEF study.

PloS one·2026
Same author

Renin, Aldosterone, and Treatment Response to Dapagliflozin, Spironolactone, and Their Combination: An Analysis From SOGALDI-PEF.

JACC. Heart failure·2026
Same author

Anthropometric adiposity measures and natriuretic peptides in heart failure screening: population-based evidence from the PORTHOS study.

European journal of heart failure·2026
Same author

Practical guide on acute heart failure management: From hospital admission to outpatient care.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026

Related Experiment Video

Updated: Mar 27, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

5.2K

Left ventricular function assessment in cirrhosis: Current methods and future directions.

Francisco Sampaio1, Joana Pimenta1

  • 1Francisco Sampaio, Cardiology Department, Centro Hospitalar de Gaia/Espinho, 4430-502 Vila Nova de Gaia, Portugal.

World Journal of Gastroenterology
|January 13, 2016
PubMed
Summary

Cirrhotic cardiomyopathy is cardiac dysfunction in cirrhosis. This review covers non-invasive imaging for assessing heart function in these patients, highlighting current and future diagnostic tools.

Keywords:
CardiomyopathyCirrhosisDeformation imagingDiastolic functionEchocardiographyMagnetic resonance imagingSystolic function

More Related Videos

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

23.3K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.5K

Related Experiment Videos

Last Updated: Mar 27, 2026

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

5.2K
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

23.3K
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

3.5K

Area of Science:

  • Cardiology
  • Hepatology
  • Medical Imaging

Background:

  • Cirrhotic cardiomyopathy (CC) is characterized by cardiac dysfunction in cirrhosis patients.
  • It involves impaired contractile responsiveness and diastolic relaxation, with electrophysiological abnormalities.
  • Diagnosis is challenging due to hyperdynamic circulation, limiting conventional methods.

Purpose of the Study:

  • To review current non-invasive imaging technologies for assessing left ventricular systolic and diastolic function in cirrhosis.
  • To explore emerging imaging modalities with future clinical potential for CC diagnosis and management.

Main Methods:

  • Literature review of non-invasive cardiovascular imaging modalities.
  • Focus on echocardiography, cardiac MRI, and CT.
  • Discussion of advanced techniques like strain imaging and cardiac biomarkers.

Main Results:

  • Echocardiography is widely used but has limitations in cirrhotic patients.
  • Newer modalities offer improved accuracy in detecting subtle cardiac dysfunction.
  • Advanced imaging can better characterize CC, aiding clinical decisions.

Conclusions:

  • Non-invasive imaging is crucial for diagnosing cirrhotic cardiomyopathy.
  • Evolving technologies promise more precise assessment of cardiac function in cirrhosis.
  • Accurate diagnosis influences patient management and prognosis.